Shanghai Rendu Biotechnology Co., Ltd.

¥43.37As of Sun 8 Nov 2026, 12:00 UTC
SSE:688193Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (7.09%)
Div yield 2.65%
ROE 2.46%
Diagnostics & Research
Beta (5Y) 0.45
PE TTM 77.04
TSR TTM (14.97%)
Mkt cap ¥1.682B
ROIC 5.62%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥45
2.83%
(71.06%)
Sell 1|3|8|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.74
0.79
0.88
0.89
12.54%
14.41%
27.24%
29.40%
Revenue¥M
186.8
189.9
192.7
197.2
8.05%
7.96%
7.76%
9.96%
Peers (US$252.1M)
Cap (US$)
PE
404.9M
94.58x
249.4M
—
Capital
TTM
5Y
10Y
Leveragex
5.023
0.351
0.270
EBIT/Intx
2.254
0.108
0.091
Own earn%
(33.47)
83.12
80.48
Sh yield%
19.66
8.83
5.48
Owners
Insiders/Inst%
3.49
66.73
Short interest%
0.62
SBC / revenue%
5.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
7–10
$1 testx
−0.1
Incr. ROIC%
5